2.3.1.23	1-acylglycerophosphocholine O-acyltransferase	alveolar cell type II	-	756102	
2.7.1.107	diacylglycerol kinase (ATP)	alveolar cell type II	-	673918	
2.7.10.2	non-specific protein-tyrosine kinase	alveolar cell type II	-	663436	
2.7.11.15	beta-adrenergic-receptor kinase	alveolar cell type II	i.e. AT2 cells, primary cells, transdifferentiation to AT1 cells	662563	
2.8.2.8	[heparan sulfate]-glucosamine N-sulfotransferase	alveolar cell type II	-	690365	
3.1.1.47	1-alkyl-2-acetylglycerophosphocholine esterase	alveolar cell type II	-	650339	
3.1.3.4	phosphatidate phosphatase	alveolar cell type II	-	134880	
3.1.3.4	phosphatidate phosphatase	alveolar cell type II	PAP-2	651209	
3.1.4.4	phospholipase D	alveolar cell type II	-	708049	
3.4.16.5	carboxypeptidase C	alveolar cell type II	-	665905	
3.4.17.23	angiotensin-converting enzyme 2	alveolar cell type II	83% of ACE2-expressing cells are alveolar epithelial type II cells	753944	
3.4.21.122	transmembrane protease serine 2	alveolar cell type II	Tmprss2 and Tmprss4 are coexpressed in alveolar and bronchial regions	754551	
3.4.21.78	granzyme A	alveolar cell type II	primary type II pneumocytes and type II pneumocyte, from patients with chronic obstructive pulmonary disease, enriched by Laser capture microdissection (LCM)	683058	
3.4.23.B1	napsin	alveolar cell type II	-	668762	
3.4.23.B1	napsin	alveolar cell type II	enzyme is detected at day 16 of gestation	669215	
3.4.23.B1	napsin	alveolar cell type II	pneumocyte type II	657686, 658356, 658694, 658695, 659282